Apogee Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:APGE) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -74.76 M-171.17 M-227.45 M -243.89 M Cash from investing activities -273.91 M-300.46 M-179.57 M -687.89 M Cash from financing activities 315.39 M495.11 M396.49 M 912.87 M Free cash flow -74.76 M-171.17 M-227.45 M -243.89 M

News

ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?

3 Best ETFs With 50%+ Upside to Buy in August 2026, According to Analysts - TipRanks.com

Stock Market Rises Amid Apple, Amazon, Meta, Microsoft Earnings, Soaring Yields: Weekly Review

Botox Maker Tops Buy Point, But Here Comes The Earnings Report

Is Apogee Therapeutics Inc. (APGE) Stock Outpacing Its Medical Peers This Year?

AbbVie Stock: A Dividend Fortress At An Appealing Price Tag (NYSE:ABBV)

Should You Buy, Sell or Hold ABBV Stock After Its 9% YTD Rise?

Biotech Euphoria Driven By Fundamentals

AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years

SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn (NYSEARCA:SBIO)

J&J or AbbVie: Which Stock Deserves a Place in Your Portfolio Now?

U.S. Equity Markets: Lots Of Gambling Going On